FeesSafety
Pluang+

Anthropic prices IPO at $83 per share, tokenized shares to debut on BNB Chain alongside Nasdaq listing

Market News
19 Nov 2026, 03:25 WIB
Tokenpost
View Source
Bullish
Anthropic prices IPO at $83 per share, tokenized shares to debut on BNB Chain alongside Nasdaq listing

Anthropic has set its initial public offering price at $83 per share for 980 million Class A shares, valuing the offering at about $81.3 billion. The company will list on Nasdaq’s Global Select Market under the ticker ANT on November 19. On the same day, tokenized versions of Anthropic shares will be available on BNB Chain through platforms like bStocks, Ondo Finance, and xStocks, providing blockchain-based exposure to the stock. However, token holders will not directly own the shares, and the tokenized products are limited to qualified investors outside the U.S. This dual launch marks a notable integration of traditional stock markets with blockchain technology.

Anthropic's IPO pricing and tokenized share launch provide context for readers. As of Nov 19, 2026 08:21 WIB, 8 of 50 major cryptocurrencies on Pluang rose while 40 fell. Notable movers include AVAX at Rp127.696 with a 3.08% decline, XLM at Rp2.491 down 2.96%, and BTC at Rp1.145.617.236 with a 2.73% drop.

More News

Micron's strong growth and rising stock price hint at a possible future stock split.

Micron's strong growth and rising stock price hint at a possible future stock split.

Micron Technology is showing strong financial growth, driven by its crucial role in AI infrastructure and multiyear deals with key tech companies. The company recently beat revenue expectations with a 379% year-over-year increase and projects even be...

Company Fundamentals
Bullish
1 hour ago
FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

The FDA has approved Livsayis™ (cemdisiran), the first and only siRNA therapy for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor antibody-positive. This subcutaneous treatment, administered four times a year, targ...

Market News
Bullish
1 hour ago
Elauwit reports 66% growth in monthly recurring revenue to $539K, cutting expenses and expanding managed Wi-Fi networks.

Elauwit reports 66% growth in monthly recurring revenue to $539K, cutting expenses and expanding managed Wi-Fi networks.

Elauwit announced a 66% year-over-year increase in monthly recurring revenue to $539,000 by the end of Q3 2026, driven by long-term contracts for managed Wi-Fi in apartment communities. The company also reduced operating expenses by 19% sequentially ...

Company Fundamentals
Bullish
1 hour ago
Montauk Renewables delays capital spending, seeks credit amendments amid operational challenges.

Montauk Renewables delays capital spending, seeks credit amendments amid operational challenges.

Montauk Renewables deferred up to $120 million in capital spending and is negotiating credit facility amendments due to operational delays at its North Carolina swine waste project. These delays have created short-term risks for debt covenants, requi...

Company Fundamentals
Neutral
1 hour ago
Palantir's revenue soars past $2B, outpacing UiPath's slower, seasonal growth in AI software sales.

Palantir's revenue soars past $2B, outpacing UiPath's slower, seasonal growth in AI software sales.

Palantir Technologies has shown rapid quarter-over-quarter revenue growth, reaching $2.3 billion in Q3 2026, driven by strong commercial adoption of its AI platform and expansion beyond government contracts. In contrast, UiPath's revenue growth is mo...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App